Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
2005-9-1
pubmed:abstractText
Chemotherapy, tamoxifen, and ovarian ablation/suppression (OA/OS) are effective adjuvant approaches for premenopausal, steroid hormone receptor-positive breast cancer. The value of combined therapy has not been clearly established.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5973-82
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16087950-Adult, pubmed-meshheading:16087950-Antineoplastic Agents, Hormonal, pubmed-meshheading:16087950-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16087950-Axilla, pubmed-meshheading:16087950-Breast Neoplasms, pubmed-meshheading:16087950-Combined Modality Therapy, pubmed-meshheading:16087950-Cyclophosphamide, pubmed-meshheading:16087950-Disease-Free Survival, pubmed-meshheading:16087950-Doxorubicin, pubmed-meshheading:16087950-Drug Administration Schedule, pubmed-meshheading:16087950-Female, pubmed-meshheading:16087950-Fluorouracil, pubmed-meshheading:16087950-Goserelin, pubmed-meshheading:16087950-Humans, pubmed-meshheading:16087950-Lymphatic Metastasis, pubmed-meshheading:16087950-Premenopause, pubmed-meshheading:16087950-Receptors, Estrogen, pubmed-meshheading:16087950-Receptors, Progesterone, pubmed-meshheading:16087950-Tamoxifen, pubmed-meshheading:16087950-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
pubmed:affiliation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St, Room 409, Baltimore, MD 21231, USA. davidna@jhmi.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural